Stift Carlanderska Sjukhuset

Goteborg 8 trials 1 recruiting

8 Registered trials

1 Currently recruiting

Organisation

Stift Carlanderska Sjukhuset

Location

Goteborg, Sweden

Identifier

ORG-100046613

Address

Carlandersparken 1, 412 55, Sweden

Departments

#7503
Carlanderska sjukhuset, Carlandersparken 1, 405 45 Göterborg
Forskningsenheten
Forskningsenheten Carlanderska
Medical Clinic
Medicinkliniken

Clinical trials at this site (8)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending

2024-516228-33-00 Type 2 Diabetes 6
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Ended

2022-502779-40-00 Primary prevention of atherosclerotic cardiovascular di 5 2023-09-04
A study to test whether BI 456906 helps people living with overweight or obesity who do not have diabetes to lose weight Ended

2022-502529-17-00 Obesity 5 2024-01-18
A study to test whether BI 456906 helps people living with overweight or obesity who also have diabetes to lose weight Ended

2022-502531-18-00 Obesity 5 2024-01-18
A study to evaluate the efficacy and safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19 Ended

2023-504540-33-00 COVID-19 5 2023-03-06
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24